Experimental Alzheimer’s Drug NU-9 Shows Promise
Researchers at Northwestern University have reported encouraging new evidence that an experimental drug may be effective as an early treatment for Alzheimer’s disease. In their latest research, scientists uncovered a previously unrecognized and highly toxic form of amyloid beta oligomers—small clusters of peptides known to damage brain cells. This newly identified subtype appears to trigger … Read more